Sevelamer Carbonate FDA approval date

The FDA approved Sevelamer Carbonate (Renvela) on 19 Oct 2007.

FDA approval date
19 Oct 2007

Drug identity checked against registry records

Also recorded as Renvela

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisNCT03427125ArdelyxPhase 3Completed2019-11-15Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2007-10-19DaySevelamer CarbonateFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA022127", "applicant_as_listed_by_fda": "SANOFI", "brand_names": ["RENVELA"], "active_ingredients": ["SEVELAMER CARBONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20071019", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026